Novartis Settles Texas Medicaid Fraud Claim Involving Elidel
November 11, 2012
It was announced on October 30, 2012 by the Texas Attorney General that the Swiss pharmaceutical company Novartis has agreed to pay $19.9 million to settle a civil Medicaid fraud enforcement action by the State of Texas and the U.S. government that alleged that it illegally marketed for “of[...]
Continue Reading
Pradaxa Lot Recalled Due To Packing Issue
November 9, 2012
The prescription drug PRADAXA is manufactured by Boehringer Ingelheim Pharmaceuticals, Inc., a large German pharmaceutical company, and is a blood thinner used to reduce the risk of stroke and systemic embolism in patients with non-valvular atrial fibrillation. Due to a packaging issue with a single[...]
Continue Reading
Missouri Vioxx Class Action Lawsuit Settled
November 5, 2012
Merck & Co. Inc. (“Merck”) has agreed to settle class action claims against it filed in Missouri regarding its former drug, Vioxx. The Missouri class action lawsuit that was filed eight years ago alleged that Merck violated the Missouri Merchandising Practices Act when it sold and [...]
Continue Reading
Another Massachusetts Compounding Pharmacy Loses License
October 31, 2012
Infusion Resource, a Massachusetts compounding pharmacy that produces sterile injectable medications for patients recently discharged from the hospital, has voluntarily surrendered its pharmacy license following an unannounced inspection of its facilities by the Massachusetts Department of Public H[...]
Continue Reading
Risk Of Nursing Home Fall Injuries Increases With SSRI Use
October 21, 2012
A British study regarding the use of SSRIs (selective serotonin reuptake inhibitors) for nursing home residents has shown an association between the use of SSRIs and an increased risk of falls causing injuries in nursing homes, with the risk increasing as the dose is increased. The study also s[...]
Continue Reading
Fungal Meningitis Outbreak: More NECC Products Are Suspected
October 16, 2012
The FDA issued a press release on October 15, 2012 regarding the ongoing fungal meningitis outbreak in the United States that is suspected to be associated with contaminated epidural steroid injections manufactured by the New England Compounding Center (“NECC”) since May 21, 2012. The [...]
Continue Reading
Chronology Of The Fungal Meningitis Outbreak
October 14, 2012
By now most people in the United States have heard about the current outbreak of fungal meningitis in the United States that has been linked to contaminated epidural steroid injections manufactured by a compounding pharmacy headquartered in Massachusetts. Three lots of the potentially contaminated[...]
Continue Reading
What Is A “Compounding Pharmacy”?
October 12, 2012
With the current attention being focused on the fungal meningitis outbreak in the United States that appears to be the result of contaminated epidural steroid injections manufactured by the compounding pharmacy, New England Compounding Center (“NECC”), you may wonder, what is a compou[...]
Continue Reading
